期刊文献+

HPLC-DAD-ELSD法同时测定牛黄镇惊丸中5个成分的含量 被引量:8

Simultaneous determination of 5 components in Niuhuang Zhenjing pills by HPLC-DAD-ELSD
原文传递
导出
摘要 目的:建立HPLC-DAD-ELSD同时测定牛黄镇惊丸中升麻素苷、甘草苷、5-O-甲基维斯阿米醇苷、甘草酸和胆酸含量的方法,为牛黄镇惊丸的质量评价提供依据。方法:采用Luna 5μC18(2)色谱柱(4.6 mm×250 mm,5μm),以乙腈-0.2%甲酸溶液为流动相,梯度洗脱,流速1.0 m L·min^(-1)。升麻素苷、甘草苷、5-O-甲基维斯阿米醇苷和甘草酸的检测波长为254 nm;胆酸使用ELSD检测器,漂移管温度110℃,氮气流速3.2 L·min^(-1)。结果:升麻素苷、甘草苷、5-O-甲基维斯阿米醇苷、甘草酸和胆酸进样量分别在0.02~0.52μg(r=0.999 9)、0.10~1.90μg(r=0.999 9)、0.03~0.58μg(r=0.999 9)、0.24~4.84μg(r=1.000 0)和0.08~1.62μg(r=1.000 0)范围内与峰面积呈现良好的线性关系;平均回收率(n=6)分别为91.4%、101.0%、104.3%、96.4%和98.9%,RSD分别为4.6%、2.4%、3.6%、3.2%和3.1%。测得8批样品中升麻素苷、甘草苷、5-O-甲基维斯阿米醇苷、甘草酸和胆酸的含量分别为0.027~0.113、0.544~0.954、0.046~0.140、0.985~1.672和0.475~1.922 mg·g^(-1)。结论:本方法可用于牛黄镇惊丸的质量控制。 Objective:To establish an HPLC-DAD-ELSD method for simultaneous determination of prim-O- glucosylcimifugin, liquiritin, 5-O-methylvisammioside, glycyrrhizic acid and cholic acid in Niuhuang Zhenjing pills. Methods: HPLC assay was performed on a Luna 5μ C18( 2 )column( 4.6 mm × 250 mm, 5μm )with a mixture of acetonitrile and 0.2% formic acid as the mobile phase in gradient elution at a flow rate of 1.0 mL·min-1. Detection wavelength forprim-O-glucosylcimifugin, liquiritin, 5-O-methylvisammioside and glycyrrhizic acid was set at 254 nm and ELSD was used for detection of cholic acid. The temperature of the drift tube was maintained at 110 ℃ and the nebulizing gas flow rate was 3.2 L·min-1. Results: The linear ranges ofprim-O-glucosylcimifugin,liquiritin, 5-O-methylvisammioside, glycyrrhizic acid and cholic acid were 0.02-0.52 μg ( r=0.999 9 ), 0.10- 1.90μg( r=0.999 9 ), 0.03-0.58μg( r=0.999 9 ), 0.24-4.84μg( r=1.000 0 )and 0.08-1.62 μg( r=l.000 0 ), respectively. The average recoveries (n=6)were 91.4% with RSD of 4.6%, 101.0% with RSD of 2.4%, 104.3% with RSD of 3.6%, 96.4% with RSD of 3,2% and 98.9% with RSD of 3.1%, respectively. The content of the above-mentioned components in 8 samples were 0.027-0.113 mg·g-1, 0.544-0.954 mg·g-1, 0.046-0.140 mg·g-1, 0.985-1.672 mg·g-1 and 0.475-1.922 mg·g-1. Conclusion: The developed method could be used in quality control of Niuhuang Zhenjing pills.
出处 《药物分析杂志》 CAS CSCD 北大核心 2017年第12期2260-2265,共6页 Chinese Journal of Pharmaceutical Analysis
关键词 牛黄镇惊丸 牛黄 防风 甘草 升麻素苷 甘草苷 5-O-甲基维斯阿米醇苷 甘草酸 胆酸 中成药质量控制 Niuhuang Zhenjing pills Bovis Calculus Saposhnikoviae Radix Glycyrrhizae Radix et Rhizoma prim-O-glucosylcimifugin liquiritin 5-O-methylvisammioside glycyrrhizic acid cholic acid quality control of Chinese patent medicine
  • 相关文献

参考文献10

二级参考文献76

  • 1HOU Yuan-yuan1,YANG Yang1,2,YAO Yang2,BAI Gang1,2 1.College of Pharmacy,Nankai University,Tianjin 300071,China 2.College of Life Sciences,Nankai University,Tianjin 300071,China.Neuroprotection of Glycyrrhizin against Ischemic Vascular Dementia in Vivo and Glutamate-induced Damage in Vitro[J].Chinese Herbal Medicines,2010,2(2):125-131. 被引量:24
  • 2洪玮,何明磊,魏东芝.18β-甘草次酸聚乙二醇轭合物的合成及其体外抗肿瘤活性[J].华东理工大学学报(自然科学版),2006,32(4):415-417. 被引量:13
  • 3王本样.现代中药药理学[M].天津科学技术出版社,1997.633.
  • 4武忠弼.病理学[M].北京:人民卫生出版社,1996.141-145.
  • 5王霞义.临床生化检验技术[M].南京:南京大学出版社,1995.180-2,185-8,279-84.
  • 6廖福龙 李文 黄深 等.大鼠血栓形成速率的评定与正常值[J].生理科学,1984,4(5):143-143.
  • 7[1]Rutherford AE,Pratt DS.Cholestasis and cholestatic syndromes[J].Curr Opin Gastroenterol,2006;22:209-14
  • 8[2]Balistreri WF,Bezerra JA,Jansen P,Karpen SJ,Shneider BL,Suchy F.Intrahepatic cholestasis:summary of an American Association for the Study of Liver Diseases single-topic conference[J].Hepatology,2005;42:222-35
  • 9[3]Hitoshi S,Wakana G,Jun-ichi Y,Masahiko K,Seiji K,Terumi T,et al.Therpeutic basis of glycyrrhizin on chronic hepatitis B[J].Antiviral Res,1996;30:171-7
  • 10[4]Goldfarb S,Singer EJ,Popper H.Experimental cholestasis due to alpha-naphthylisothiocyanate (ANIT)[J].Am J Pathol,1962;40:685-98

共引文献248

同被引文献121

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部